| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Royalcare Super Speciality Hospital Limited |
|
Particulars |
2023 |
2022 |
|
I. EQUITY AND LIABILITIES |
|
|
|
(1) Shareholder’s Funds |
|
|
|
(a) Share Capital |
16,437.69 |
16,437.69 |
|
(b) Reserves & Surplus |
-3,066.67 |
-4,634.18 |
|
(2) Share Application Money pending allotment |
- |
- |
|
(3) Non-Current Liabilities |
|
|
|
(a) Long-Term Borrowings |
20,346.00 |
21,250.45 |
|
(b) Other Long Term Liabilities |
460.67 |
- |
|
(c) Long Term Provisions |
599.03 |
600.58 |
|
(4) Current Liabilities |
|
|
|
(a) Short - Term Borrowings |
4,002.39 |
4,351.69 |
|
(b) Trade Payables |
|
|
|
(A) total outstanding dues of MSME; and |
565.7 |
15.47 |
|
(B) total outstanding dues of Creditors other MSME |
680.91 |
600.64 |
|
(c) Other Current Liabilities |
1,239.53 |
1,220.23 |
|
(d) Short-Term Provisions |
801 |
720 |
|
Total |
42,066.25 |
40,562.57 |
|
II. ASSETS |
|
|
|
(1) Non-Current Assets |
|
|
|
(a) Property, Plant and Equipment & Intangible Assets |
|
|
|
(i) Property, Plant and Equipment |
33,115.53 |
33,110.15 |
|
(ii) Intangible Assets |
108.8 |
47.37 |
|
(iii) Capital work in progress |
1,253.52 |
1,014.70 |
|
|
34,477.85 |
34,172.22 |
|
(b) Non-Current Investment |
116 |
116.55 |
|
(c) Deferred Tax Asset (net) |
157.4 |
146.16 |
|
(d) Long-term Loans and Advances |
1,607.69 |
1,475.22 |
|
(e) Other non - current assets |
1,190.51 |
818.54 |
|
(2) Current Assets |
|
|
|
(a) Inventories |
901.2 |
650.5 |
|
(b) Trade Receivables |
1,685.53 |
911.72 |
|
(c) Cash and Cash Equivalents |
504.38 |
831.02 |
|
(d) Short-Term Loans and Advances |
1,315.22 |
1,301.48 |
|
(e) Other Current Assets |
110.47 |
139.16 |
|
Total |
42,066.25 |
40,562.57 |
|
Particulars |
2023 |
2022 |
|
I Revenue from operations |
30,548.55 |
30,115.37 |
|
II Other income |
516.4 |
421.96 |
|
III Total Income |
31,064.95 |
30,537.33 |
|
IV Expenses: |
|
|
|
Consumables-Hospital & Stores |
6,856.82 |
7,122.75 |
|
Purchase of Stock-in-Trade |
2,981.45 |
2,615.80 |
|
Changes in Inventories |
-26.77 |
-31.59 |
|
Service Expenses |
7,075.64 |
6,077.54 |
|
Employee Benefit Expenses |
5,379.79 |
5,253.50 |
|
Finance Cost |
2,683.62 |
2,717.48 |
|
Depreciation and Amortization Expenses |
2,438.91 |
2,372.07 |
|
Other Expenses |
2,119.22 |
2,277.75 |
|
Total Expenses (IV) |
29,508.68 |
28,405.30 |
|
V Profit/(Loss) before Tax |
1,556.27 |
2,132.03 |
|
VI Tax Expenses |
|
|
|
(1) Current Tax ( Including Provisions) |
271.91 |
229.68 |
|
Less : MAT Credit Entitlement |
-271.91 |
-229.68 |
|
(2) Deferred tax (Income)/Expenses |
-11.24 |
8.84 |
|
VII Profit/(Loss) for the year (VI-VII) |
1,567.51 |
2,123.19 |
|
VIII Earning per equity share in Rupees |
|
|
|
(1) Basic / Diluted (Face value of ` 10 each) |
0.95 |
1.29 |
|
Particulars |
2023 |
2022 |
|
CASH FLOW FROM OPERATING ACTIVITIES |
|
|
|
Profit/(Loss) Before Taxation and after Exceptional Items |
1556.27 |
2132.03 |
|
ADJUSTMENTS FOR:- |
|
|
|
Depreciation and Amortisation |
2438.91 |
2,372.07 |
|
Interest Income |
-154.48 |
-138.83 |
|
Finance Cost |
2683.63 |
2,717.48 |
|
Operating profit before working capital changes |
6524.33 |
7082.75 |
|
ADJUSTMENTS FOR:- |
|
|
|
(Increase) / Decrease In Inventories |
-250.71 |
42.97 |
|
(Increase) / Decrease In Trade Receivables |
-773.81 |
-53.94 |
|
(Increase) / Decrease In Short Term Loans & Advances |
-13.75 |
-409.4 |
|
(Increase) / Decrease In Other Current Assets |
28.68 |
-51.8 |
|
Increase / (Decrease) In Current Liability |
381.5 |
1,729.00 |
|
Income Tax Paid |
- |
- |
|
Net Cash Genrated from /(Used In) Operating Activity |
5896.24 |
8,339.58 |
|
CASH FLOW FROM INVESTMENT ACTIVITIES |
|
|
|
Purchase of Fixed Assets |
-1491.02 |
-3446.02 |
|
Capital WIP |
-1253.52 |
-1014.7 |
|
Interest Received |
154.48 |
138.83 |
|
Net Cash Generated from (Used In ) Investing Activities |
-2590.06 |
-4321.89 |
|
CASH FLOW FROM FINANCING ACTIVITIES |
|
|
|
Finance Cost |
-2683.62 |
-2717.48 |
|
Increase / (Decrease) In Long Term Borrowings |
-904.45 |
554.83 |
|
Increase / (Decrease) In Long Term Provisions |
-1.55 |
192.2 |
|
Increase / (Decrease) In Long Term -Trade Payables |
460.67 |
- |
|
(Increase) / Decrease In Long Term Loans & Advances |
-132.46 |
-858.63 |
|
(Increase) / Decrease Non Current Assets |
-371.97 |
-688.79 |
|
(Increase) / Decrease In Non Current Investments |
0.55 |
- |
|
Net Cash From / (Used In) Financing Activities |
-3632.83 |
-3,517.87 |
|
Increase/(Decrease) In Cash and Cash Equivalents |
-326.63 |
499.83 |
|
Cash and Cash Equivalents at the Beginning of the Year |
831.02 |
331.19 |
|
Cash and Cash Equivalents at the End of the Year |
504.38 |
831.02 |
|
Cash on Hand |
33.95 |
39.68 |
|
Balance With Bank |
470.43 |
791.34 |
Certainly, here is a summary of the Cash Flow Statement for the years 2023 and 2022:
Cash Flow from Operating Activities:
- 2023: Rs. 5,896.24 million
- 2022: Rs. 8,339.58 million
Cash Flow from Investing Activities:
- 2023: Rs. (-2,590.06) million
- 2022: Rs. (-4,321.89) million
Cash Flow from Financing Activities:
- 2023: Rs. (-3,632.83) million
- 2022: Rs. (-3,517.87) million
Overall Change in Cash and Cash Equivalents:
- 2023: Rs. (-326.63) million
- 2022: Rs. 499.83 million
Details regarding Cash and Cash Equivalents:
- Cash on Hand 2023: Rs. 33.95 million; 2022: Rs. 39.68 million
- Balance with Bank 2023: Rs. 470.43 million; 2022: Rs. 791.34 million
|
Ratio |
2023 |
2022 |
|
Current Ratio |
0.62 |
0.55 |
|
Debt Equity Ratio |
1.76 |
2.09 |
|
Debt Service Coverage Ratio |
1.12 |
1.55 |
|
Retun on Equity Ratio |
12.45% |
19.80% |
|
Inventory Turnover Ratio |
39.37 |
44.82 |
|
Trade Receivable Ratio |
23.52 |
34.04 |
|
Trade Payable Ratio |
10.8 |
13.76 |
|
Net Capital Turnover Ratio |
-11.02 |
-9.8 |
|
Net Profit Ratio |
5.13 |
7.05 |
|
Return on Capital Employed |
11.50% |
13.30% |
|
Return on Investment |
4.30% |
6.20% |
Here is a summary of the financial and operational metrics for Royalcare Super Speciality Hospital Limited for the years 2023 and 2022:
Liquidity Ratios:
Royalcare 's liquidity, as depicted by the current ratio, improved slightly from 0.55 in 2022 to 0.62 in 2023. Despite this increase, the company still faces challenges in meeting short-term obligations with its current assets.
Leverage Ratios:
The debt equity ratio shows a decline from 2.09 in 2022 to 1.76 in 2023, indicating a relatively lower reliance on debt to finance assets. This decrease might suggest improved financial stability as compared to the previous year.
Debt Service Coverage Ratio:
There 's a notable decrease in the debt service coverage ratio from 1.55 in 2022 to 1.12 in 2023, indicating a lower ability to cover debt obligations from operating income. This might raise concerns regarding the company 's debt repayment capability.
Profitability Ratios:
The return on equity (ROE) declined from 19.80% in 2022 to 12.45% in 2023, suggesting a decrease in the company 's ability to generate profits from shareholders ' equity. Similarly, the net profit ratio also dropped from 7.05% to 5.13%, indicating reduced profitability.
Efficiency Ratios:
Despite a slight decrease in the inventory turnover ratio from 44.82 in 2022 to 39.37 in 2023, the company maintains a healthy turnover of inventory. However, the trade receivable ratio decreased from 34.04 in 2022 to 23.52 in 2023, which could signify better management of receivables.
The trade payable ratio also decreased from 13.76 in 2022 to 10.8 in 2023, showing a potentially improved ability to meet short-term obligations. However, the net capital turnover ratio remained negative in both years, indicating inefficiencies in capital utilization.
